SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2,513 Cr | ₹-7,906 Cr | ₹-6,710 Cr | ₹2,376 Cr | ₹-5,193 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-2,513 Cr |
| Mar2025 | ₹-7,906 Cr |
| Mar2024 | ₹-6,710 Cr |
| Mar2023 | ₹2,376 Cr |
| Mar2022 | ₹-5,193 Cr |
How is Cash Flow from Financing Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2,513 Cr | Negative | |
| Mar2025 | ₹-7,906 Cr | Negative | |
| Mar2024 | ₹-6,710 Cr | Negative | |
| Mar2023 | ₹2,376 Cr | Positive | |
| Mar2022 | ₹-5,193 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,060.9 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
| MANKIND PHARMA | ₹99,089.5 Cr | -4.5% | 2.7% | -2.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% |
-6.6% |
7.3% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses